Skip to content

Akoya Biosciences, Inc.

CIK 0001711933

← back to feed
Revenue (TTM)
$76.97M
−15.5% YoY Q1 Apr 2025
Net Income (TTM)
−$62.82M
+12.6% YoY Q1 Apr 2025
EPS Diluted (TTM)
−$1.28
+21.7% YoY Q1 Apr 2025
Gross Margin
56.3%
Q1 Apr 2025
Operating Margin
-70.7%
Q1 Apr 2025
Net Margin
-81.6%
Q1 Apr 2025
Free Cash Flow (TTM)
−$68.68M
Q1 Apr 2025
Cash
$20.36M
Q1 Apr 2025
Total Debt
$152.67M
Q1 Apr 2025
Shares Outstanding
49.88M sh
Q1 Apr 2025

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings